China Minsheng Banking Corp., Ltd.
China Minsheng Banking Corp., Ltd. (CGMBF) Financial Performance & Income Statement Overview
Analyze China Minsheng Banking Corp., Ltd. (CGMBF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
China Minsheng Banking Corp., Ltd. (CGMBF) Income Statement & Financial Overview
Analyze China Minsheng Banking Corp., Ltd.’s CGMBF earnings with segmented quarterly and yearly financial statement figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $25.95B | $34.63B | $34.53B | $74.11B |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $25.95B | $34.63B | $34.53B | $74.11B |
Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $10.11B | $16.97B | $18.61B | $10.52B |
Operating Expenses | $10.11B | $17.96B | $34.53B | $10.10B |
Total Costs & Expenses | $10.11B | $17.96B | $34.53B | $66.05B |
Interest Income | $0.00 | $60.87B | $62.25B | $63.00B |
Interest Expense | $0.00 | $35.93B | $37.09B | $38.68B |
Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $2.20B |
EBITDA | $0.00 | $0.00 | $8.58B | $10.42B |
EBITDA Ratio | $0.00 | $0.00 | $0.25 | $0.14 |
Operating Income | $15.85B | $16.67B | -$37.09B | -$179.00M |
Operating Income Ratio | $0.61 | $0.48 | -$1.07 | -$0.002 |
Other Income/Expenses (Net) | -$1.60B | -$14.65B | $45.67B | $259.00M |
Income Before Tax | $14.25B | $2.03B | $8.58B | $8.22B |
Income Before Tax Ratio | $0.55 | $0.06 | $0.25 | $0.11 |
Income Tax Expense | $1.46B | $22.00M | $574.00M | -$999.00M |
Net Income | $12.74B | $1.81B | $8.01B | $9.04B |
Net Income Ratio | $0.49 | $0.05 | $0.23 | $0.12 |
EPS | $0.29 | $0.04 | $0.18 | $0.21 |
Diluted EPS | $0.29 | $0.04 | $0.18 | $0.21 |
Weighted Avg Shares Outstanding | $43.94B | $16.39B | $43.78B | $43.78B |
Weighted Avg Shares Outstanding (Diluted) | $43.94B | $22.70B | $43.78B | $43.78B |
Over the last four quarters, China Minsheng Banking Corp., Ltd. achieved steady financial progress, growing revenue from $74.11B in Q2 2024 to $25.95B in Q1 2025. Gross profit stayed firm with margins at 100% in Q1 2025 versus 100% in Q2 2024. Operating income totaled $15.85B in Q1 2025, maintaining a 61% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $0.00. Net income rose to $12.74B, with EPS at $0.29. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan